| Name | arginyl-tRNA synthetase 1 |
| Description | Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Arginyl-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nHuman RARS1 encodes the cytoplasmic arginyl-tRNA synthetase (ArgRS), a key enzyme that catalyzes the esterification of L‑arginine to its cognate tRNA—a critical step in protein translation. Structural and biochemical studies have revealed that ArgRS possesses an extended N‑terminal domain that is essential for its integration into the multi‑aminoacyl tRNA synthetase complex (MSC), where it forms critical contacts with auxiliary factors such as AIMP1. Crystallographic analyses further demonstrate that binding of L‑arginine or its analogs induces subtle conformational changes that optimize substrate recognition and catalytic efficiency. Moreover, alternative translational initiation generates two distinct ArgRS isoforms: one that is MSC‑associated and another that remains free in the cytosol, potentially diversifying its cellular functions. Recent work also indicates that binding of regulatory molecules like hemin to a conserved site in the Add1 domain can induce oligomerization and inhibit enzyme activity, suggesting additional layers of functional modulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMutations and rearrangements of RARS1 have been associated with a spectrum of human diseases. Biallelic variants in RARS1 underlie hypomyelinating leukodystrophies and Pelizaeus–Merzbacher–like disease, where altered enzyme function or reduced protein abundance leads to inefficient protein synthesis and impaired myelin formation. Distinct pathogenic mechanisms have been described—from amino acid substitutions that disrupt catalytic activity to mutations that introduce upstream open reading frames causing translational suppression. In addition, fusion events such as RARS‑MAD1L1 have been identified in nasopharyngeal carcinoma, where the aberrant protein promotes cell proliferation, enhances cancer stem cell–like properties, and confers chemoradioresistance through activation of the FUBP1/c‑Myc pathway. Furthermore, RARS1 influences the processing and secretion of cytokine precursors, thereby potentially contributing to neurodegenerative and inflammatory pathologies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "11"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its conventional role in protein synthesis, RARS1 also participates in intricate protein–protein networks that modulate additional cellular processes. Its appended domains are critical for interactions with other synthetases—such as the leucyl-tRNA synthetase—ensuring proper assembly and function of the MSC. Moreover, overexpression of RARS1 has been shown to alter the secretion and proteolytic processing of cytokine precursors (for example, pro‑endothelial monocyte‑activating polypeptide II), linking its activity to pathways that govern neuronal integrity and tumor behavior. In contrast to mitochondrial aminoacyl‑tRNA synthetases—which display unique sub‑mitochondrial localizations dictated by hydrophobic and electrostatic interactions—the cytoplasmic localization of RARS1 underscores its specialized role in eukaryotic translation and cellular regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fang Yang, Xian Xia, Hui-Yan Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hemin binds to human cytoplasmic arginyl-tRNA synthetase and inhibits its catalytic activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.159913"}], "href": "https://doi.org/10.1074/jbc.M110.159913"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20923763"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20923763"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Nicole I Wolf, Gajja S Salomons, Richard J Rodenburg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in RARS cause hypomyelination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.24167"}], "href": "https://doi.org/10.1002/ana.24167"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24777941"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24777941"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hyun Sook Kim, So Young Cha, Chang Hwa Jo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The crystal structure of arginyl-tRNA synthetase from Homo sapiens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2014.05.027"}], "href": "https://doi.org/10.1016/j.febslet.2014.05.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24859084"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24859084"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Fang Yang, Quan-Quan Ji, Liang-Liang Ruan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The mRNA of human cytoplasmic arginyl-tRNA synthetase recruits prokaryotic ribosomes independently."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.562454"}], "href": "https://doi.org/10.1074/jbc.M114.562454"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24898251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24898251"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yaoyao Fu, Youngran Kim, Kyeong Sik Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the ArgRS-GlnRS-AIMP1 complex and its implications for mammalian translation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1408836111"}], "href": "https://doi.org/10.1073/pnas.1408836111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25288775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25288775"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Arianna Bottoni, Cristina Vignali, Daniela Piccin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.21083"}], "href": "https://doi.org/10.1002/jcp.21083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17443684"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17443684"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Haiming Xu, Nikolay L Malinin, Niranjan Awasthi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.630533"}], "href": "https://doi.org/10.1074/jbc.M114.630533"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25724651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25724651"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Michael Nafisinia, Nara Sobreira, Lisa Riley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ejhg.2017.119"}], "href": "https://doi.org/10.1038/ejhg.2017.119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28905880"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28905880"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Qian Zhong, Zhi-Hua Liu, Zhi-Rui Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "RARS-MAD1L1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-0352"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-0352"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29133573"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29133573"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Marisa I Mendes, Lydia M C Green, Enrico Bertini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RARS1-related hypomyelinating leukodystrophy: Expanding the spectrum."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Clin Transl Neurol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/acn3.50960"}], "href": "https://doi.org/10.1002/acn3.50960"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31814314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31814314"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Guang Li, Gilbert Eriani, En-Duo Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct pathogenic mechanisms of various RARS1 mutations in Pelizaeus-Merzbacher-like disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci China Life Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11427-020-1838-2"}], "href": "https://doi.org/10.1007/s11427-020-1838-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33515434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33515434"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Chen Ling, Yong-Neng Yao, Yong-Gang Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The C-terminal appended domain of human cytosolic leucyl-tRNA synthetase is indispensable in its interaction with arginyl-tRNA synthetase in the multi-tRNA synthetase complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M413511200"}], "href": "https://doi.org/10.1074/jbc.M413511200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16055448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16055448"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Ligia Elena González-Serrano, Loukmane Karim, Florian Pierre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Three human aminoacyl-tRNA synthetases have distinct sub-mitochondrial localizations that are unaffected by disease-associated mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.003400"}], "href": "https://doi.org/10.1074/jbc.RA118.003400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30006346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30006346"}]}]}]}
|
| NCBI Gene ID | 5917 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
RARS1 has 3,477 functional associations with biological entities spanning 6 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 45 datasets.
Click the + buttons to view associations for RARS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of RARS1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of RARS1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with RARS1 protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of RARS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with RARS1 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of RARS1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing RARS1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing RARS1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with RARS1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for RARS1 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving RARS1 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with RARS1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with RARS1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with RARS1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving RARS1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving RARS1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing RARS1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing RARS1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by RARS1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by RARS1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of RARS1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of RARS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of RARS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with RARS1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of RARS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of RARS1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving RARS1 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of RARS1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of RARS1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by RARS1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for RARS1 protein from the MW Gene Metabolite Associations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving RARS1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| Reactome Pathways 2024 | pathways involving RARS1 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of RARS1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of RARS1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of RARS1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of RARS1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of RARS1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of RARS1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of RARS1 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of RARS1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of RARS1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of RARS1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with RARS1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving RARS1 protein from the WikiPathways Pathways 2024 dataset. | |